Topics

Glioblastoma | Etiopathogenesis | Microenvironment | Immunosuppression

Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Microenvironment > Immunosuppression

Nicolaou N, Andreou MS, Neophytou CM, Papageorgis P.
Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy.
Front Immunol. 2025 Oct 24;16:1665742. doi: 10.3389/fimmu.2025.1665742. PMID: 41208963. Review. ˍ

Wei Y, Shi Y, Wang H, Shang Y, Yu B, Zhang Y.
Glioblastoma insights: Focus on crosstalk with the suppressive tumor microenvironment and advanced therapeutic strategies.
Medicine (Baltimore). 2025 Dec 5;104(49):e46285. doi: 10.1097/MD.0000000000046285. PMID: 41366964. Review. ˍ

Pang C, Wang Y.
The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions.
Immunology. 2025 Dec 19. doi: 10.1111/imm.70087. PMID: 41414954. Review. ˍ

Figg JW, Flores CT.
Rewriting microenvironment immunity in glioblastoma.
Mol Ther Oncol. 2026 Jun 9;34(2):201245. doi: 10.1016/j.omton.2026.201245. PMID: 42291139. ˍ

Yang J, Li J, Jin M, Lu Y, Zhang L.
The immunosuppressive tumor microenvironment in glioblastoma.
Front Immunol. 2026 Jul 2;17:1806996. doi: 10.3389/fimmu.2026.1806996. PMID: 42465775. ˍ